Vaccine Adjuvant License and Collaboration AgreementConfidential Treatment • March 5th, 2009 • Celldex Therapeutics, Inc. • In vitro & in vivo diagnostic substances • Minnesota
Contract Type FiledMarch 5th, 2009 Company Industry JurisdictionThis Agreement is made on the 30th day of May, 2008 (“Effective Date”) by and among 3M COMPANY (“3M”) and 3M INNOVATIVE PROPERTIES COMPANY (“3M IPC”), a wholly-owned subsidiary of 3M, both with a principal address as 3M Center, St. Paul, MN 55144 (collectively “3M”); and Celldex Therapeutics, with a principal address at 222 Cameron Drive Suite 400, Phillipsburg, NJ 08865 (“CELLDEX”).
Vaccine Adjuvant License and Collaboration AgreementConfidential Treatment • March 2nd, 2009 • Celldex Therapeutics Inc • Biological products, (no disgnostic substances) • Minnesota
Contract Type FiledMarch 2nd, 2009 Company Industry JurisdictionThis Agreement is made on the 30th day of May, 2008 (“Effective Date”) by and among 3M COMPANY (“3M”) and 3M INNOVATIVE PROPERTIES COMPANY (“3M IPC”), a wholly-owned subsidiary of 3M, both with a principal address as 3M Center, St. Paul, MN 55144 (collectively “3M”); and Celldex Therapeutics, with a principal address at 222 Cameron Drive Suite 400, Phillipsburg, NJ 08865 (“CELLDEX”).